Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Merck & Co. reports glucokinase activators as diabetes treatment candidates

Aug. 14, 2014

First-in-class APOBEC3 enzyme inhibitors identified as potential oncolytic candidates

Aug. 14, 2014

Novel small-molecule GK-GKRP inhibitors with the ability to lower blood glucose levels in vivo

Aug. 14, 2014

Pfizer presents DGAT2 inhibitors with activity in preclinical models of metabolic disease

Aug. 14, 2014

In vivo results demonstrate high potential of FR-104 for clinical transplantation

Aug. 13, 2014

Development of a rapid point-of-care diagnostic test EBOV and SUDV detection

Aug. 13, 2014

PDE10A inhibitors for the treatment of schizophrenia

Aug. 13, 2014

BMS-986118, a novel potent dual-acting GPR40 agonist for the treatment of diabetes

Aug. 13, 2014

Optimization of RORc inverse agonists from Genentech

Aug. 13, 2014

miRNA biomarkers identified for oesophageal squamous cell carcinoma detection and prognosis

Aug. 12, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...